A propósito de un caso de paraganglioma
Texto completo:
HTMLResumen
Referencias
Pinto A, Barletta JA. Adrenal Tumors in Adults. Surg Pathol Clin. 2015 Dec;8(4):725-49.
Young WF. Médula suprarrenal, catecolaminas y feocromocitoma. En: Cecil y Goldman. Tratado de medicina interna. 24ª ed. Madrid: Elsevier; 2013. p. 1474-9.
Kiernan C, Solórzano C. Pheochromocytoma and Paraganglioma. Surg Oncol Clin N Am. 2016;25(1):119-38.
Mannelli M, Castellano M, Schiavi F, Filetti S, Giacchè M, Mori L, et al. Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab. 2009;94:1541-7.
Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26:551-6.
Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: The expanding genetic differential diagnosis. J Natl Cancer Inst. 2003;95:1196-204.
Maher ER, Eng C. The pressure rises: update on the genetics of pheochromocytoma. Hum Mol Genet. 2002;11:2347-54.
Bernal C, Alcázar JM. Feocromocitoma: presentación clínica. Diagnóstico y tratamiento. Hipertensión. 2006;23(6):173-83.
Landsberg L, Young JB. Feocromocitoma. En: Harrison TR. Principios de Medicina Interna. 14ª ed. Madrid: McGraw-Hill Interamericana; 1998. p. 2337.
Herbert C, Sippel R, O'Dorisio M, Vinik A, Lloyd R, Pacak K. The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer. Pancreas. 2010;39(6):775-83.
Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427-34.
Van Duinen N, Steenvoorden D, Kema IP, Jansen JC, Vriends AH, Bayley JP, et al. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab. 2010;95:209-14.
Manger WM, Eisenhofer G. Pheocrhomocytoma: diagnosis and management update. Curr Hypert Rep. 2004;6:477-84.
Taieb D, Sebag F, Hubbard JG, Mundler O, Henry JF, Conte-Devolx B. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial pheochromocytoma? Clin Endocrinol. 2004;61:102-8.
Cascon A, Pita G, Burnichon N, Landa I, López-Jiménez E, Montero-Conde C, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab. 2009;94:1701-5.
Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134:315-29.
Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665-75.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2016 Valentina Acosta-Ramón, Maite Estíbaliz López de Goicoecha-Saiz, Emilio Pariente-Rodrigo
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.